drugset / Trial / NCT01180335
Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer
RandomizedFactorialOpen-labelTreatment
Summary
This randomized trial is comparing a standard neoadjuvant chemotherapy with a genomic driven chemotherapy in patients with breast cancer.
Timeline
- Start
- 2009-01
- Primary completion
- 2010-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | — |
| Comparator | Docetaxel | Small molecule | — | — |
| Subject | Paclitaxel | Small molecule | — | — |